[go: up one dir, main page]

TW200637862A - 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes - Google Patents

1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes

Info

Publication number
TW200637862A
TW200637862A TW095100702A TW95100702A TW200637862A TW 200637862 A TW200637862 A TW 200637862A TW 095100702 A TW095100702 A TW 095100702A TW 95100702 A TW95100702 A TW 95100702A TW 200637862 A TW200637862 A TW 200637862A
Authority
TW
Taiwan
Prior art keywords
substituted
methanimidamidyl
cyano
compounds
fluoranthenes
Prior art date
Application number
TW095100702A
Other languages
English (en)
Inventor
Bart Rudolf Romanie Kesteleyn
Pierre Jean-Marie Raboisson
De Vreken Wim Van
Maxime Francis Jean-Marie Canard
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of TW200637862A publication Critical patent/TW200637862A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW095100702A 2005-01-10 2006-01-09 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes TW200637862A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05100092 2005-01-10

Publications (1)

Publication Number Publication Date
TW200637862A true TW200637862A (en) 2006-11-01

Family

ID=34938497

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095100702A TW200637862A (en) 2005-01-10 2006-01-09 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes

Country Status (12)

Country Link
US (1) US7514427B2 (zh)
EP (1) EP1838709B1 (zh)
JP (1) JP2008526814A (zh)
CN (1) CN101103029B (zh)
AR (1) AR056918A1 (zh)
AT (1) ATE538121T1 (zh)
AU (1) AU2006204475B2 (zh)
BR (1) BRPI0606475A2 (zh)
CA (1) CA2584425A1 (zh)
RU (1) RU2389730C2 (zh)
TW (1) TW200637862A (zh)
WO (1) WO2006072636A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011529085A (ja) 2008-07-25 2011-12-01 ギリアード サイエンシーズ, インコーポレイテッド 抗ウイルス化合物
AU2012292947B2 (en) 2011-08-05 2017-02-16 Biota Scientific Management Pty Ltd Compounds for treating respiratory syncytial virus infections
US9975906B2 (en) 2014-05-16 2018-05-22 Shionogi & Co., Ltd. Tricyclic heterocycle derivatives having HIV replication inhibitory effect
WO2016194806A1 (ja) * 2015-05-29 2016-12-08 塩野義製薬株式会社 Hiv複製阻害作用を有する含窒素3環性誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2220509C (en) * 1995-05-31 2005-07-05 Eisai Co., Ltd. Fused polycyclic heterocycle derivatives
DE19538088A1 (de) * 1995-10-13 1997-04-17 Bernd Prof Dr Clement Phenanthridinderivate und ihre Herstellung
NZ540321A (en) * 2002-11-15 2007-09-28 Tibotec Pharm Ltd Substituted indolepyridinium as anti-infective compounds

Also Published As

Publication number Publication date
AU2006204475A1 (en) 2006-07-13
WO2006072636A3 (en) 2006-12-14
EP1838709B1 (en) 2011-12-21
WO2006072636A2 (en) 2006-07-13
CA2584425A1 (en) 2006-07-13
CN101103029A (zh) 2008-01-09
RU2389730C2 (ru) 2010-05-20
ATE538121T1 (de) 2012-01-15
CN101103029B (zh) 2010-12-29
US20080167296A1 (en) 2008-07-10
US7514427B2 (en) 2009-04-07
JP2008526814A (ja) 2008-07-24
EP1838709A2 (en) 2007-10-03
RU2007130550A (ru) 2009-02-20
BRPI0606475A2 (pt) 2009-06-30
AR056918A1 (es) 2007-11-07
AU2006204475B2 (en) 2011-03-10

Similar Documents

Publication Publication Date Title
TNSN08407A1 (en) Organic compounds
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
TW200745117A (en) Macrocylic inhibitors of hepatitis C virus
PH12012501711A1 (en) [5,6] heterocyclic compound
WO2007122634A3 (en) Pyrimidinediones as tyrosine kinase inhibitors
MX2009011276A (es) Inhibidor de dpp-iv que incluye el grupo beta-amino, metodo para la preparacion del mismo y composicion farmaceutica que contiene el mismo para prevenir y tratar una diabetes o una obesidad.
WO2008142055A3 (en) Antiviral agents
WO2010068760A3 (en) New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
TW200640908A (en) Chemical compounds
WO2009001060A3 (en) Use of compounds for preparing anti-tuberculosis agents
WO2009016462A3 (en) Substituted bicyclolactam compounds
NZ594930A (en) Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
MX2010006397A (es) Compuestos heterociclicos antivirales.
NO20090628L (no) Pyridizinon derivativater
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
WO2006084017A3 (en) Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
WO2008079836A3 (en) Macrocyclic factor viia inhibitors useful as anticoagulants
NZ592165A (en) Novel combinations of antibacterial nitrogenous heterocyclic compounds with other antibacterial compounds, and use thereof as drugs
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
MX2010008039A (es) Compuestos triciclicos que tienen actividad antagonista de factor de liberacion de corticotropina y composiciones farmaceuticas que contienen los mismos.
CL2011000784A1 (es) Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales.
WO2008116815A3 (en) Compounds
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.